Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Jeffrey R. Andolina, M.D., M.S.
Jeffrey R. Andolina, M.D., M.S.

Jeffrey R. Andolina, M.D., M.S.

Pediatrics — Hematology/Oncology — Pediatric Hematology-Oncology

Accepting New Patients

Jeffrey R. Andolina, M.D., M.S.

Pediatrics — Hematology/Oncology — Pediatric Hematology-Oncology

Accepting New Patients


Locations

jeffrey_andolina@urmc.rochester.edu
UR Medicine
Pediatric Hematology Oncology Division
601 Elmwood Ave - Box 777
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-2981

print

Fax

(585) 273-1039

About Me

Dr. Andolina is most interested in the treatment and comprehensive care for children with leukemia and lymphoma, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML), as well as the care for children with other cancers and blood diseases.

Dr. Andolina is the director of pediatric bone marrow transplantation and has experience in treating both leukemias as well as non-malignant conditions such as aplastic anemia. He has a particular interest in bone marrow transplant for patients with sickle cell anemia. In addition, Dr. Andolina has an interest in the adolescent and young adult population, and also cares for young adults undergoing bone marrow transplantation.

The University of Rochester is a member of the Children's Oncology Group (COG) and the Pediatric Blood and Marrow Tissue Consortium (PBMTC). Dr. Andolina is the primary investigator for our institution for these national cooperative groups. We have over 75 clinical trials open and strive to have all front-line treatment studies open for our pediatric and young adult patients.

Dr. Andolina admits to:

Strong Memorial Hospital

Credentials

Education:

MD | University of Virginia School of Medicine — 2004

Post-doctoral Training & Residency:

Residency in Pediatrics at Children's Memorial Hospital, Northwestern University — 2005 - 2007
Internship in Pediatrics at Children's Memorial Hospital, Northwestern University — 2004 - 2005
Fellowship in Pediatric Hematology/Oncology at Children's Memorial Hospital, Northwestern University — 2007 - 2010

Research

Dr. Andolina is interested in improving the outcome for children with cancer through offering enrollment on multi-institutional clinical trials through the Children's Oncology Group (COG) and Pediatric Blood and Marrow Tissue Consortium (PBMTC).

Dr. Andolina has a particular interest in Pediatric Bone Marrow Transplantation; Leukemia; Lymphoma; Neuroblastoma; Hematology, Oncology; Pediatric Hematology Oncology; Pediatric Oncology; Pediatric Cancer.

Other research interests include evaluating donor anti-HLA antibodies and patient outcome after bone marrow transplant, as well as evaluating reduced-intensity conditioning regimens for children with malignant and non-malignant diseases, especially sickle cell anemia.

Dr. Andolina also performs laboratory research including the study of the gene expression profile of acute lymphoblastic leukemia cells, specifically evaluating gene expression changes which may confer survival advantages post-allogeneic hematopoietic stem cell transplantation.

Publications:

Kaplan FS, Andolina JR, Adamson PC, Teachey DT, Finklestein JZ, Ebb DH, Whitehead B, Jacobs B, Siegel DM, Keen R, Hsiao E, Pignolo RJ. "Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases." Bone.. 2017 Jul 20; Epub 2017 Jul 20.

Devine, K.A., Viola, A., Capucilli, P., Sahler, O.J., Andolina, .J.R. "Factors Associated with Noncompliance with Long-term Follow-up care among Pediatric Cancer Survivors". J. Pediatric Hematology Oncology. 2017; .

Pina C, Khattab A, Katzman P, Bruckner L, Andolina J, New M, Yau M. "Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy." Journal of pediatric endocrinology & metabolism : JPEM.. 2015 May 0; 28(5-6):663-7.

View All Publications